2Senior R,Sumit MB,Christopher K,et al.Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction[J].Am Heart J,1999,137(3):646-652.
1Everly MJ, Heaton PC, Cluxton RJ Jr. Beta-blocker underuse in secondary prevention of myocardial infarction[J]. Ann Pharmacother,2004,38(2):286-293.
2Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction[J]. JAMA,1997,277(2):115-121.
3Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure[J]. Am J Med,2002,113(8):650-656.
4Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: insights from the BEST study[J]. J Am Coll Cardiol,2003,42(12):2128-2134.
5Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% trea
6Poole-Wilson PA, Swedberg K, Cleland JG, et al. Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COME
7Cleland JG, Pennell DJ, Ray SG, et al. Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS tria
8CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial[J]. Lancet,1999,353(9146):9-13.
9Ormiston TM, Salpeter SR. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice[J]. Heart Fail Monit,2003,4(2):45-54.
10Khand AU, Rankin AC, Martin W, et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure[J]? J Am Coll Cardiol,2003,42(11):1944-1951.
